Clinical care of the HIV-infected drug user
- PMID: 17502234
- PMCID: PMC2128697
- DOI: 10.1016/j.idc.2007.03.009
Clinical care of the HIV-infected drug user
Abstract
HIV/AIDS and chemical dependency, the latter often intertwined with mental illness, are complex, overlapping spheres that adversely influence each other and the overall clinical outcomes of the affected individual. Each disorder individually impact tens of millions of people adversely, with explosive epidemics described worldwide. This article addresses the adverse consequences of HIV/AIDS, drug injection, the secondary comorbidities of both, and the impact of immunosuppression on presentation of disease as well as approaches to managing the HIV-infected drug user.
Figures
Similar articles
-
Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs.Lancet. 2010 Jul 31;376(9738):367-87. doi: 10.1016/S0140-6736(10)60829-X. Lancet. 2010. PMID: 20650518 Free PMC article. Review.
-
Primary care of the HIV-seropositive chemically dependent patient.Prim Care. 1997 Sep;24(3):667-76. Prim Care. 1997. PMID: 9271698 Review.
-
Consequences of drug abuse and HIV/AIDS in China: recommendations for integrated care of HIV-infected drug users.AIDS Patient Care STDS. 2009 Oct;23(10):877-84. doi: 10.1089/apc.2009.0015. AIDS Patient Care STDS. 2009. PMID: 19799494 Review.
-
Triple diagnosis: dual diagnosis and HIV disease, Part 1.AIDS Read. 2003 Jul;13(7):331-2, 339-41. AIDS Read. 2003. PMID: 12889451 Review.
-
The overlapping epidemics of viral hepatitis/HIV, addiction and incarceration: the situation in Rhode Island.Med Health R I. 2005 Dec;88(12):424-7. Med Health R I. 2005. PMID: 16408715 No abstract available.
Cited by
-
Optimizing care for HIV-infected people who use drugs: evidence-based approaches to overcoming healthcare disparities.Clin Infect Dis. 2013 Nov;57(9):1309-17. doi: 10.1093/cid/cit427. Epub 2013 Jun 23. Clin Infect Dis. 2013. PMID: 23797288 Free PMC article. Review.
-
Improving public health through access to and utilization of medication assisted treatment.Int J Environ Res Public Health. 2011 Oct;8(10):4102-17. doi: 10.3390/ijerph8104102. Epub 2011 Oct 24. Int J Environ Res Public Health. 2011. PMID: 22073031 Free PMC article. Review.
-
Lack of reduction in buprenorphine injection after introduction of co-formulated buprenorphine/naloxone to the Malaysian market.Am J Drug Alcohol Abuse. 2009;35(2):68-72. doi: 10.1080/00952990802585406. Am J Drug Alcohol Abuse. 2009. PMID: 19212931 Free PMC article.
-
Perceived Mistreatment in Health Care Settings and its Relationship with HIV Clinical Outcomes in HIV-positive People who Use Drugs in Vancouver, Canada.AIDS Behav. 2023 May;27(5):1636-1646. doi: 10.1007/s10461-022-03895-z. Epub 2022 Nov 1. AIDS Behav. 2023. PMID: 36318426 Free PMC article.
-
Therapeutic drug monitoring of protease inhibitors and efavirenz in HIV-infected individuals with active substance-related disorders.Ther Drug Monit. 2011 Jun;33(3):309-14. doi: 10.1097/FTD.0b013e31821d3adb. Ther Drug Monit. 2011. PMID: 21544014 Free PMC article. Clinical Trial.
References
-
- Bruce RD, Altice FL. Why treat three conditions when it is one patient? AIDS Read. 2003;13(8):378–9. - PubMed
-
- Altice F, Friedland GH. Epidemiology of HIV infection and AIDS: past, present, and future. Disease Management and Health Outcomes. 1997;1(6):304–22.
-
- Douaihy AB, Jou RJ, Gorske T, et al. Triple diagnosis: dual diagnosis and HIV disease, part 2. AIDS Reader. 2003;13(8):375–82. see comment. - PubMed
-
- Douaihy AB, Jou RJ, Gorske T, et al. Triple diagnosis: dual diagnosis and HIV disease, Part 1. AIDS Reader. 2003;13(7):331–2. - PubMed
-
- Risk behaviors for HIV transmission among intravenous-drug users not in drug treatment–United States, 1987–1989. MMWR Morb Mortal Wkly Rep. 1990;39(16):273–6. - PubMed